XKRX
001630
Market cap121mUSD
Jul 10, Last price
39,400.00KRW
1D
2.47%
1Q
-17.23%
Jan 2017
-42.82%
Name
Chongkundang Holdings Corp
Chart & Performance
P/E
4.64
P/S
0.20
EPS
8,492.65
Div Yield, %
—
Shrs. gr., 5y
0.01%
Rev. gr., 5y
2.25%
Revenues
959.01b
+0.13%
Net income
40.43b
+20.34%
CFO
76.04b
+210.56%
Dividend
Dec 27, 20241400 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Seoul, South Korea, Chong Kun Dang Holdings Corp. has manufactured and supplied pharmaceutical goods since its inception in 1941, reaching both South Korean and global markets.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||